概述
In critically-ill patients the development of hyperglycemia secondary to the acute lesion stress is common even in non-diabetics. Hyperglycemia and the
metabolic consequences of insulin resistance increase
morbidity and mortality in critically-ill patients1
,
because they enhance the occurrence of infections and
multiple organ failure, mainly due to proinflammatory
effects and cell toxicity per se of high glycemia values.
